Business

‘India, China, Pak are illicit drug-producing nations’

By Sohail Khan 16 September 2026, 9:57 pm

Benchmarks
Nifty23,217.6099.0

FEATURED FUNDS★★★★★

Motilal Oswal Midcap Fund Direct-Growth

5Y Return
22 %

Invest Now

Enter search text:

Business News›Industry›Healthcare/Biotech›Pharmaceuticals›US names India, China, Pakistan among drug transit, illicit drug-producing nations for FY27

Read Today's Paper

US names India, China, Pakistan among drug transit, illicit drug-producing nations for FY27
Synopsis

The United States has designated India, China, and Pakistan as major drug producing or transit countries. This presidential determination covers twenty-three nations for fiscal year twenty twenty-seven. Afghanistan, Bolivia, Burma, and Colombia were separately identified for failing counternarcotics obligations. Inclusion on the list considers geographic and economic factors for drug production and transport. This designation does not necessarily reflect current government efforts or US cooperation.

US names India, China, Pakistan among illicit drug-producing nations for FY27 — U.S President Donald Trump has named India, China, Pakistan among major drug transit, production countries for FY27

The US named included India, China and Pakistan in its list of “major drug transit or major illicit drug producing countries” for fiscal year 2027, while separately identifying Afghanistan, Bolivia, Burma and Colombia as countries that failed demonstrably to meet their international counternarcotics obligations.

The presidential determination, submitted to Congress, covers 23 countries and clarified that inclusion on the list does not necessarily reflect a government’s current counternarcotics efforts or its cooperation with the US.

Countries are included based on geographic, commercial and economic factors that allow drugs or precursor chemicals to be produced or transported through their territory.

India on US major drug transit, production list

India was named among the 23 countries named in the FY2027 determination.

The United States welcomed Prime Minister Narendra Modi and the Indian government’s efforts to tackle illicit opium poppy cultivation and strengthen supply-chain integrity. Washington also said it looks forward to continued cooperation with India through the US-India Drug Policy Framework.

India's inclusion on the list is therefore accompanied by a specific acknowledgement of ongoing cooperation on counternarcotics issues.

China flagged over precursor chemicals

China is also mentioned in the FY2027 list, with the determination highlighting its role in the production of precursor chemicals used in illicit synthetic drugs.

The US said China remains the world’s largest producer of many precursor chemicals used to manufacture fentanyl, methamphetamine and other synthetic drugs. It said Beijing needs to take more aggressive action, including scheduling additional chemical precursors and substances sought by the US.

Pakistan among 23 countries

Pakistan has also been identified as a major drug transit or illicit drug-producing country for FY2027.

However, it is not among the four countries the US has separately designated as having “failed demonstrably” during the previous 12 months to make substantial counternarcotics efforts.

The four countries receiving that designation are Afghanistan, Bolivia, Burma and Colombia. The US also determined that assistance to Bolivia, Burma and Colombia is currently vital to its national interests.

What the US drug designation means

The US determination explicitly says that appearing on the major drug transit or illicit drug-producing countries list does not necessarily indicate that a government is failing to combat drug trafficking.

Under the determination, countries can be included because geographic, commercial and economic conditions facilitate the transit or production of drugs or precursor chemicals, even where governments have undertaken “robust and diligent” narcotics-control and law-enforcement measures.

23 countries on FY2027 list

The countries named in the determination include Afghanistan, The Bahamas, Belize, Bolivia, Burma, China, Colombia, Costa Rica, the Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, India, Jamaica, Laos, Mexico, Nicaragua, Pakistan, Panama, Peru and Venezuela.

Separately, the US designated Afghanistan, Bolivia, Burma and Colombia as having failed demonstrably to meet their counternarcotics obligations over the previous 12 months.

Add as a Reliable and Trusted News Source
Add Now!

(You can now subscribe to our WhatsApp channel)

(Catch all the Business News, Breaking News and Latest News Updates on The .)

…moreless

(You can now subscribe to our WhatsApp channel)

Read More News on
united statesus newsIndiaDrug TransitMajor Illicit Drug Producing Countries

(Catch all the Business News, Breaking News and Latest News Updates on The .)

…moreless

Enter search text:

Continue reading with one of these options:
Limited Access
Free
Login to get access to some exclusive stories

& personalised newsletters
Login Now

Unlimited Access
Starting @ Rs120/month
Get access to exclusive stories, expert opinions &

in-depth stock reports
Subscribe Now

Unlock Access to All Exclusives with ETPrime FREE TRIAL

15 Days Free: Unlock All ETPrime Exclusives, Market Tools & ePapers

Trial offer expiring in00 : 05 : 00

I'd rather pay ₹2599 now

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Prime Account Detected!

It seems like you're already an ETPrime member with

Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits.

Unlock ETPrime's Exclusive Stories Today!

Subscribe to gain powerful insights on business, stock market and industry trends.

Big Price Drop! Flat 40% Off

Student Only Offer

Already a Member? Sign In now

Already a Member? Sign In now
Already a Member? Sign In now

Offer Exclusively For You

Save up to Rs. 700/-

ON ET PRIME MEMBERSHIP

Avail Offer

Offer Exclusively For You

Get 1 Year Free

With 1 and 2-Year ET prime membership

Avail Offer

Offer Exclusively For You

Get 1 Year Free

With 1 and 2-Year ET prime membership

Avail Offer

Offer Exclusively For You

Get Flat 40% Off

Then ₹ 1749 for 1 year

Avail Offer

Offer Exclusively For You

ET Prime at ₹ 49 for 1 month

Then ₹ 1749 for 1 year

Avail Offer

Special Offer

Get flat 40% off on ETPrime

Avail Offer
Avail Offer

Claim NowAlready a Member? Sign In now

Need Assistance?

Connect with an ETPrime expert for personalized support and guidance

+91 9484700004

' + h3 + '

' + h4 + '

' + listing + '

What’s Included with

ETPrime Membership

1Exclusive Insights That Matter

Uncover the truth with our investigative stories

Make strategic moves using the real-world case studies

Read industry-specific stories to identify emerging trends

Spot opportunities with in-depth insights that matter

Trump temper on H-1B visas is forcing Indians to do these things to stay put in US

What Adani’s US indictment means for India Inc’s overseas fundraising
Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer.

Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?
Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?

The problem with lab grown diamonds
Why a falling rupee is a better option for the economy

A list of top 20 momentum stocks that have delivered massive returns in one year